US2014017784A1PendingUtilityA1
Methods for Expansion and Analysis of Cultured Hematopoietic Stem Cells
Est. expiryMay 24, 2025(expired)· nominal 20-yr term from priority
C12N 5/00C12N 2501/145A61P 37/04C12N 2501/113C12N 2501/17A61P 7/04A61P 7/00A61P 7/06C12N 2501/105C12N 2500/90A61P 31/18A61P 31/04C12N 5/0647C12N 2501/125A61K 2035/124C12N 2501/91
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and kits for propagating hematopoietic stem cells are provided. The methods comprise culturing cells in medium comprising one or more angiopoietin-like proteins, under conditions sufficient for expansion of HSCs. Angiopoietin-like proteins include angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and microfibrillar-associated glycoprotein (Mfap4). Methods for identifying hematopoietic stem cells are provided and isolated hematopoietic stem cells are also provided.
Claims
exact text as granted — not AI-modified1 - 38 . (canceled)
39 . A kit for propagating hematopoietic stem cells (HSCs) in vitro comprising:
a) medium suitable for culturing one or more cells comprising an HSC, b) at least one angiopoietin-like protein, and c) at least one additional growth factor selected from the group consisting of insulin-like growth factor (IGF), fibroblast growth factor (FGF), thrombopoietin (TPO), and stem cell factor (SCF).
40 - 46 . (canceled)
47 . The kit of claim 39 , wherein the angiopoietin-like protein is selected from the group consisting of angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and Mfap4.
48 . The kit of claim 39 , wherein when in use, the angiopoietin-like protein is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL.
49 . The kit of claim 39 , wherein the angiopoietin-like protein is a recombinant protein.
50 . The kit of claim 39 , wherein the kit comprises SCF.
51 . The kit of claim 39 , wherein when in use, the additional growth factor is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL.
52 . The kit of claim 39 , wherein the one or more cells are selected from the group consisting of bone marrow cells, umbilical cord blood cells, and fetal liver cells.
53 . The kit of claim 39 , wherein the one or more cells are human cells.
54 . The kit of claim 39 , wherein the one or more cells are primary cells.
55 . The kit of claim 39 , further comprising an instruction to culture the one or more cells for at least five days.
56 . A kit for propagating hematopoietic stem cells (HSCs) in vitro comprising:
a) medium suitable for culturing primary cells comprising an HSC; b) at least one angiopoietin-like protein selected from the group consisting of angiopoietin-like protein 2, angiopoietin-like protein 3, angiopoietin-like protein 4, angiopoietin-like protein 5, angiopoietin-like protein 7, and Mfap4; and c) at least one additional growth factor selected from the group consisting of insulin-like growth factor (IGF), fibroblast growth factor (FGF), thrombopoietin (TPO), and stem cell factor (SCF).
57 . The kit of claim 56 , wherein when in use, the angiopoietin-like protein is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL
58 . The kit of claim 56 , wherein the angiopoietin-like protein is a recombinant protein.
59 . The kit of claim 56 , wherein the kit comprises SCF.
60 . The kit of claim 56 , wherein when in use, the additional growth factor is present in the medium at a concentration of about 0.1 ng/mL to about 500 ng/mL
61 . The kit of claim 56 , wherein the primary cells are selected from the group consisting of bone marrow cells, umbilical cord blood cells, and fetal liver cells.
62 . The kit of claim 56 , wherein the primary cells are human cells.
63 . The kit of claim 56 , further comprising an instruction to culture the one or more cells for at least five days.
64 . A method of propagating hematopoietic stem cells (HSCs) in vitro comprising:
(a) providing the kit of claim 39 ; and (b) culturing the one or more cells in the medium comprising the angiopoietin-like protein and the additional growth factor.
65 . A method of propagating hematopoietic stem cells (HSCs) in vitro comprising:
(a) providing the kit of claim 56 ; and (b) culturing the primary cells in the medium comprising the angiopoietin-like protein and the additional growth factor.Join the waitlist — get patent alerts
Track US2014017784A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.